---
title: 'Manufacturing Daily Summary: What Happened on November 16, 2026'
headline: ProBioGen gains expanded GMP authorization for Berlin facility
description: The updated certificate adds viral products and advanced therapy medicines
  to the facility’s existing protein-manufacturing services.
url: https://thebench.bio/news/manufacturing/2026-11-16
topic: manufacturing
date: '2026-11-16'
covers:
- '2026-11-16'
date_published: '2026-11-16T12:02:43Z'
date_modified: '2026-11-17T00:03:18Z'
tags:
- Manufacturing
sources: 1
publisher: TheBench.Bio
---

# Manufacturing Daily Summary: What Happened on November 16, 2026

**ProBioGen gains expanded GMP authorization for Berlin facility**

The updated certificate adds viral products and advanced therapy medicines to the facility’s existing protein-manufacturing services.

## Today in brief

ProBioGen received expanded manufacturing authorization for its Berlin facility, adding viral products and advanced therapy medicines to its GMP services. [1]

## Manufacturing

An updated GMP certificate allows ProBioGen’s Berlin facility to produce sterile biological drug substances and investigational medicines, including viral vectors and vaccines. [1] The facility has capacity for up to 200 liters of drug substance. [1]

## The day in numbers

- **200 liters**: Maximum drug-substance production capacity at ProBioGen’s Berlin facility. [1]

## Also published

- [The resilience gap: Why good intentions aren't enough in biopharma supply chains](<https://www.bioprocessintl.com/supply-chain/the-resilience-gap-why-good-intentions-aren-t-enough-in-biopharma-supply-chains>), BioProcess International
- [Completing the circle: the next evolution in sustainable pharmaceutical blister packaging](<https://www.biopharmadive.com/spons/completing-the-circle-the-next-evolution-in-sustainable-pharmaceutical-bli/874350/>), BioPharma Dive

## Sources

1. [ProBioGen secures extended GMP authorisation for viral manufacturing facility](<https://pharmafile.com/news/probiogen-secures-extended-gmp-authorisation-for-viral-manufacturing-facility/>), Pharmafile, 2026-11-16

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://pharmafile.com/news/probiogen-secures-extended-gmp-authorisation-for-viral-manufacturing-facility/>
